Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial. (Q54566127)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial. |
scientific article |
Statements
Higher efficacy of letrozole in combination with trastuzumab compared to letrozole monotherapy as first-line treatment in patients with HER2-positive, hormone-receptor-positive metastatic breast cancer - results of the eLEcTRA trial. (English)
1 reference
1 reference
P A Fasching
1 reference
M W Beckmann
1 reference
J Huober
1 reference
M Barsoum
1 reference
D Wallwiener
1 reference
C Thomssen
1 reference
T Reimer
1 reference
S Paepke
1 reference
H A Azim
1 reference
V Ragosch
1 reference
E Kubista
1 reference
A K Baumgärtner
1 reference
C May
1 reference
I Nimmrich
1 reference
N Harbeck
1 reference
8 September 2011
1 reference
1 reference
21
1 reference
1
1 reference
27-33
1 reference
Identifiers
1 reference